Wolverine Trading, LLC Xenon Pharmaceuticals Inc. Put Options Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$28.7 - $46.46 $585,480 - $947,784
-20,400 Reduced 80.63%
4,900 $225,000
Q3 2023

Nov 15, 2023
BUY
$34.16 - $39.73 $864,247 - $1.01 Million
25,300 New
25,300 $864,000
Q2 2022

Aug 15, 2022
SELL
$25.44 - $35.16 $193,344 - $267,216
-7,600 Reduced 53.15%
6,700 $207,000
Q1 2022

May 16, 2022
BUY
$25.09 - $33.13 $70,252 - $92,764
2,800 Added 24.35%
14,300 $431,000
Q4 2021

Feb 14, 2022
BUY
$15.6 - $35.4 $179,400 - $407,100
11,500 New
11,500 $368,000

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.42B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email